X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Coupled deglycosylation-ubiquitination cascade in regulating PD-1 degradation by MDM2.

Zhen Wu | Zhijie Cao | Han Yao | Xiaojun Yan | Wenbin Xu | Mi Zhang | Zishan Jiao | Zijing Zhang | Jianyuan Chen | Yajing Liu | Meng Zhang | Donglai Wang
Cell reports | 2023

Posttranslational modifications represent a key step in modulating programmed death-1 (PD-1) functions, but the underlying mechanisms remain incompletely defined. Here, we report crosstalk between deglycosylation and ubiquitination in regulating PD-1 stability. We show that the removal of N-linked glycosylation is a prerequisite for efficient PD-1 ubiquitination and degradation. Murine double minute 2 (MDM2) is identified as an E3 ligase of deglycosylated PD-1. In addition, the presence of MDM2 facilitates glycosylated PD-1 interaction with glycosidase NGLY1 and promotes subsequent NGLY1-catalyzed PD-1 deglycosylation. Functionally, we demonstrate that the absence of T cell-specific MDM2 accelerates tumor growth by primarily upregulating PD-1. By stimulating the p53-MDM2 axis, interferon-α (IFN-α) reduces PD-1 levels in T cells, which, in turn, exhibit a synergistic effect on tumor suppression by sensitizing anti-PD-1 immunotherapy. Our study reveals that MDM2 directs PD-1 degradation via a deglycosylation-ubiquitination coupled mechanism and sheds light on a promising strategy to boost cancer immunotherapy by targeting the T cell-specific MDM2-PD-1 regulatory axis.

Pubmed ID: 37379210 RIS Download

Research resources used in this publication

Additional research tools detected in this publication

None found

Antibodies used in this publication

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Cleaved Caspase-3 (Asp175) Antibody (antibody)

RRID:AB_2341188

This polyclonal targets Cleaved Caspase-3 (Asp175)

View all literature mentions

Rabbit monoclonal D4W2Z anti-CD8 (antibody)

RRID:AB_2756376

This recombinant monoclonal targets CD8

View all literature mentions

FITC anti-mouse/human CD44 (antibody)

RRID:AB_312956

This monoclonal targets CD44

View all literature mentions

PE anti-mouse CD8a (antibody)

RRID:AB_312747

This monoclonal targets CD8a

View all literature mentions

APC anti-mouse CD4 (antibody)

RRID:AB_312697

This monoclonal targets CD4

View all literature mentions

TCF11/NRF1 (D5B10) Rabbit mAb (antibody)

RRID:AB_11178947

This monoclonal targets TCF11/NRF1 (D5B10) Rabbit mAb

View all literature mentions

Beta Actin antibody (antibody)

RRID:AB_2687938

This monoclonal targets Beta Actin

View all literature mentions

NGLY1 Polyclonal Antibody (antibody)

RRID:AB_2763292

This polyclonal targets NGLY1

View all literature mentions

Monoclonal Anti-Vinculin antibody produced in mouse (antibody)

RRID:AB_477629

This monoclonal targets Vinculin antibody produced in mouse

View all literature mentions

TP53-human (antibody)

RRID:AB_628082

This monoclonal targets TP53

View all literature mentions

DDDDK-Tag (ECS/Enterokinase Cleavage Site) Polyclonal Antibody (antibody)

RRID:AB_591224

This polyclonal targets DDDDK-Tag (ECS/Enterokinase Cleavage Site)

View all literature mentions

LC3B (D11) XP Rabbit mAb (antibody)

RRID:AB_2137707

This monoclonal targets LC3B (D11) XP Rabbit mAb

View all literature mentions

MDM2 (E3G5I) Rabbit mAb (antibody)

RRID:AB_2936381

This monoclonal targets MDM2

View all literature mentions

MDM2 (SMP14) (antibody)

RRID:AB_627920

This monoclonal targets detection of MDM2, MDM2 p60 cleavage product and p53-MDM2 complexes

View all literature mentions

MDM2 (D1V2Z) (antibody)

RRID:AB_2784534

This monoclonal targets MDM2

View all literature mentions

InVivoPlus anti-mouse CD8α (antibody)

RRID:AB_10950145

This monoclonal targets CD8α

View all literature mentions

anti-mouse CD4 (antibody)

RRID:AB_1107636

This monoclonal targets CD4

View all literature mentions

InVivoPlus anti-mouse PD-1 (CD279) (antibody)

RRID:AB_10949053

This monoclonal targets PD-1 (CD279)

View all literature mentions

PD-1 (D4W2J) XP® (antibody)

RRID:AB_2728833

This monoclonal targets PD-1

View all literature mentions

STOCK Mdm2tm2.1Glo/J (organism)

RRID:IMSR_JAX:031614

Mus musculus with name STOCK Mdm2tm2.1Glo/J from IMSR.

View all literature mentions